184 related articles for article (PubMed ID: 9201430)
1. Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants.
Withold W; Friedrich W; Degenhardt S
Clin Chim Acta; 1997 May; 261(2):105-15. PubMed ID: 9201430
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K status in relation to bone metabolism in patients with renal failure.
Małyszko J; Wołczyński S; Skrzydlewska E; Małyszko JS; Myśliwiec M
Am J Nephrol; 2002; 22(5-6):504-8. PubMed ID: 12381951
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of osteoblast activity with an immunoradiometric assay for determination of bone alkaline phosphatase mass concentration in patients receiving renal transplants.
Withold W; Degenhardt S; Castelli D; Heins M; Grabensee B
Clin Chim Acta; 1994 Mar; 225(2):137-46. PubMed ID: 8088003
[TBL] [Abstract][Full Text] [Related]
4. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies.
Azinge EC; Bolarin DM
Niger J Physiol Sci; 2006; 21(1-2):21-5. PubMed ID: 17242729
[TBL] [Abstract][Full Text] [Related]
5. Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation.
Withold W; Degenhardt S; Grabensee B; Reinauer H
Clin Chim Acta; 1995 Aug; 239(2):143-51. PubMed ID: 8542652
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
7. Serum osteocalcin and bone mineral metabolism following successful renal transplantation.
Boiskin I; Epstein S; Ismail F; Thomas SB; Raja R
Clin Nephrol; 1989 Jun; 31(6):316-22. PubMed ID: 2665993
[TBL] [Abstract][Full Text] [Related]
8. Serum osteocalcin levels in primary hyperparathyroidism.
Pietschmann P; Niederle B; Anvari A; Woloszczuk W
Klin Wochenschr; 1991 May; 69(8):351-3. PubMed ID: 1886398
[TBL] [Abstract][Full Text] [Related]
9. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
10. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
Joffe P; Hyldstrup L; Heaf JG; Pødenphant J; Henriksen JH
Am J Nephrol; 1992; 12(6):419-24. PubMed ID: 1292341
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.
Lepage OM; Marcoux M; Tremblay A
Can J Vet Res; 1990 Apr; 54(2):223-6. PubMed ID: 2357658
[TBL] [Abstract][Full Text] [Related]
13. Influence of sex and age on biochemical bone metabolism parameters.
Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
[TBL] [Abstract][Full Text] [Related]
14. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
Alexandersen P; Hassager C; Riis BJ
Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
[TBL] [Abstract][Full Text] [Related]
15. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Nagasue K; Inaba M; Okuno S; Kitatani K; Imanishi Y; Ishimura E; Miki T; Kim M; Nishizawa Y
Biomed Pharmacother; 2003 Mar; 57(2):98-104. PubMed ID: 12842495
[TBL] [Abstract][Full Text] [Related]
16. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
[TBL] [Abstract][Full Text] [Related]
17. Osteocalcin, skeletal alkaline phosphatase, and bone mineral content in very low birth weight infants: a longitudinal assessment.
Pittard WB; Geddes KM; Hulsey TC; Hollis BW
Pediatr Res; 1992 Feb; 31(2):181-5. PubMed ID: 1542549
[TBL] [Abstract][Full Text] [Related]
18. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
19. Osteocalcin serum levels in patients following renal transplantation.
Schmidt H; Stracke H; Schatz H; Scheuermann EH; Fassbinder W; Schoeppe W
Klin Wochenschr; 1989 Mar; 67(5):297-303. PubMed ID: 2651790
[TBL] [Abstract][Full Text] [Related]
20. Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy.
Cundy T; Kanis JA
Clin Chim Acta; 1987 May; 164(3):285-91. PubMed ID: 3297429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
